Thursday, 14 January 2021

Catheters Market Technological Advancements And Mounting Demand Forecast till 2028: Grand View Research Inc.

 

Catheter Market Growth & Trends

The global catheter market size is anticipated to reach USD 74.84 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2021 to 2028. The increasing prevalence of chronic diseases and improving medical facilities are some of the prime attributes boosting the market growth. Moreover, the rapidly growing geriatric population base has led to increased hospitalization rates and surgeries, which is anticipated to boost the market growth.

The rise in the prevalence of various chronic disorders, such as cardiovascular disorders, urology disorders, strokes, and other chronic conditions, is expected to increase the demand and use of catheters in medical settings. As per the WHO, every year, 41 million people die due to chronic illnesses, which accounts for 71% of all deaths globally and 60% of the global burden of disease in 2020. Thus, with the rise in these diseases, the use of catheters is bound to increase over the study period. Moreover, an increasing number of people in developing countries of APAC and Latin America are suffering from diabetes owing to factors, such as sedentary lifestyle and dietary irregularities. This, in turn, is expected to boost the use of catheters in medical settings.

Technological advancements play a crucial role in driving the catheters market. For instance, the introduction of miniaturized and antimicrobial catheters to reduce catheter-associated infections is expected to favor the market growth. For instance, Teleflex introduced Arrow acute hemodialysis catheters based on ARROWg+ard Antimicrobial Technology, which is known for its broad-spectrum of antimicrobial protection.

Request a free sample copy or view report summary: Catheter Market Report

Catheter Market Report Highlights

  • On the basis of product type, the cardiovascular catheters segment dominated the market in 2020 with a share of 28.03% owing to the rise in the prevalence of cardiovascular disorders which, in turn, is increasing the demand for the interventional cardiac procedures
  • Based on distribution channel, the hospital stores segment dominated the market in 2020 with a share of 53.83% owing to an increase in the number of hospital admission rates and an upsurge in surgical procedures globally
  • North America dominated the market with a revenue share of 32.05% in 2020 owing to the high incidence rate of chronic disorders as well as the availability of highly skilled physicians in this region

Catheter Market Segmentation

Grand View Research has segmented the global catheters market on the basis of product type, distribution channel, and region: 

Catheter Product Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Cardiovascular
  • Urology
  • Intravenous
  • Neurovascular
  • Specialty

Catheter Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals Stores
  • Retail Stores
  • Others

Catheter Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Catheter Market

  • Hollister Incorporated
  • Medtronic
  • Boston Scientific Corporation
  • Edward Lifesciences
  • Smith Medical Inc.
  • Teleflex Incorporated
  • ConvaTec Group Plc
  • Cure Medical LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wednesday, 13 January 2021

Burn Care Market Soaring Demand Assures Motivated Revenue Share By 2028

 Burn Care Market Growth & Trends

The global burn care market size is expected to reach USD 3.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.9% from 2021 to 2028. Increasing incidences of burn injuries are anticipated to fuel the demand for cost-effective treatment over the forecast period. As per the WHO, 96.0% of fatal fire-related burns occur in low to middle-income countries. According to the data published by WHO, on average 265,000 deaths are caused by burns every year. The majority of these deaths occur in low to middle-income countries and half of them occur in South East Asia. Moreover, around 1,000,000 people in India are moderately or severely burnt and around 173,000 children in Bangladesh are burnt each year. It also reported that in the U.S., approximately 4,500 burn victims die annually and 10,000 die due to burn-related infections. Owing to this substantial increase in the number of burn incidences, the patient population for burn care and treatment has increased. This in turn is expected to drive market growth over the forecast period.

Furthermore, due to the rising incidences of burn, the demand for treatment options is increasing and as a result, the overall healthcare expenditure on burn care is increasing. Treatment options for burn care include advanced dressings, biologics, traditional burn care products, and others. The foam dressings developed from semipermeable polyurethane are waterproof and can be used on heavily exuding wounds. As a result of which they are preferred over normal dressings which are not waterproof and need to be changed regularly.

Request a free sample copy or view report summary: Burn Care Market Report

Burn Care Market Report Highlights

  • The moist wound dressing segment dominated the market in 2020 due to the rising technological advancements and increasing demand for advanced treatment options
  • On the basis of depth of wound, the partial thickness burn segment is anticipated to witness the fastest growth over the forecast period. The growth of the segment is attributable to the favorable reimbursement policies in the developed countries
  • The hospitals segment accounted for the largest share of the market owing to the increasing incidence of burn injuries and hospitalizations each year
  • The thermal burns segment held the largest share of the market in 2020 owing to a high incidence of fire-related burn injuries

Burn Care Market Segmentation

Grand View Research has segmented the burn care market on the basis of the product, depth of wound, cause, end-use, and region:

Burn Care Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Advanced Dressing
    • Alginate Dressing
    • Collagen Dressing
    • Hydrogel Dressing
    • Hydrocolloid Dressings
    • Wound Contact Layers
    • Film Dressings
    • Foam Dressings
    • Others
  • Biologics
  • Traditional Burn Care Products
  • Others

Burn Care Depth of Wound Outlook (Revenue, USD Million, 2016 - 2028)

  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns

Burn Care Cause Outlook (Revenue, USD Million, 2016 - 2028)

  • Thermal Burns
  • Electrical Burns
  • Radiation Burns
  • Chemical Burns
  • Friction Burns

Burn Care End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Clinics
  • Others

Burn Care Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

List of Key Players of Burn Care Market

  • 3M
  • Hollister Incorporated
  • Cardinal Health
  • Integra LifeSciences Corporation
  • KCI Licensing, Inc. (Acelity L.P. Inc.)
  • Coloplast Corp.
  • DeRoyal Industries, Inc.
  • Smith & Nephew
  • ConvaTec Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Animal Health Market Will Target Emerging Markets by 2028

 

Animal Health Market Growth & Trends

The global animal health market size is expected to reach USD 74.5 billion by 2028 registering a CAGR of 5.9%, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in veterinary care. For instance, MediLabSecure, a laboratory network project (2014-2021), was initiated to identify emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, the emergence of veterinary health information systems, specifically in developed economies, is expected to provide high growth potential in the future.

With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. Incorporation of this technology will facilitate real-time analysis for fluctuations in disease prevalence. As a result of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of veterinary health products, which is anticipated to fuel market growth.

North America captured the largest share of the global market owing to technological advancements, rising incidence of zoonotic diseases, an increasing number of pet owners, and a wide range of definitive measures adopted by welfare organizations. Asia Pacific is expected to exhibit the fastest CAGR over the forecast years as a result of consistent R&D investments by prominent players and their efforts to commercialize branded and generic therapeutics at competitive prices.

Key market participants employ sustainability strategies, such as expanding product portfolio, to gain a competitive advantage. For instance, in April 2019, Merck acquired Antelliq Corp., operational in the field of digital animal identification, traceability, and monitoring solutions. This acquisition helped the former company improve its veterinary vaccines and pharmaceutical solutions portfolio.

Request a free sample copy or view report summary: Animal Health Market Report

Animal Health Market Report Highlights

  • The vaccines product segment is expected to exhibit lucrative growth due to a significant increase in the adoption of pets, which demands long-term health plans
  • The companion animal type segment is anticipated to register the fastest CAGR from 2021 to 2028 owing to associated health benefits for humans, such as greater psychological stability and reduced anxiety attacks
  • The retail and e-commerce distribution channels accounted for notable shares owing to factors, such as convenience associated with online platforms and an increasing number of retail pharmacies
  • Point-of-care is the second-fastest-growing end-use segment. The growth is attributed to an increase in demand for productive animals and growing investments in R&D for novel animal products
  • In 2020, North America accounted for the largest share of the global market owing to the presence of established pharmaceutical companies consistently striving for extensive commercialization of their products
  • Asia Pacific is anticipated to be the fastest-growing regional market over the forecast years owing to high clinical urgency to curb incidence of zoonotic diseases and management of disease outbreaks, such as swine influenza and Ebola

Animal Health Market Segmentation

Grand View Research has segmented the global animal health market on the basis of animal type, product, distribution channel, end-use, and region:

Animal Health Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Production
    • Poultry
    • Swine
    • Cattle
    • Sheep & Goats
    • Fish
  • Companion
    • Dogs
    • Cats
    • Horses
    • Others

Animal Health Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Vaccines
    • Live Attenuated Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Others
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Others
  • Feed Additives
    • Nutritional
    • Medicinal
  • Diagnostics
    • Instruments
    • Consumables
  • Others

Animal Health Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Retail
  • E-commerce
  • Veterinary Hospitals & Clinics

Animal Health End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Reference Laboratories
  • Point-of-Care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

Animal Health Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Russia
    • Spain
    • The Netherlands
    • Switzerland
    • Sweden
    • Ireland
    • Poland
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Thailand
    • Australia
    • South Korea
    • Philippines
    • Malaysia
    • Singapore
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • United Arab Emirates
    • Israel

List of Key Players of Animal Health Market

  • Merck Animal Health
  • Ceva Santé Animale
  • Vetiquinol S.A.
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Elanco
  • Nutreco N.V.
  • Virbac
  • Heska Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Social Commerce Market Size Is Predicted To Reach A Valuation Of USD 3,369.8 Billion By 2028: Grand View Research Inc.

 Social Commerce Market Growth & Trends

The global social commerce market size is expected to reach USD 3,369.8 billion by 2028, according to a study conducted by Grand View Research, Inc. It is anticipated to expand at a CAGR of 28.4% from 2021 to 2028. Social commerce is the incorporation of social media and e-commerce, which is used for selling and promoting products and services. The market is primarily driven by the growing number of social media users, along with rising built-in e-commerce projects. For instance, in March 2019, Instagram launched a checkout feature, which allows users to complete the purchase process without having to leave the app.

The rising adoption of social media platforms or shopping and information exchange is expected to fuel market growth. Moreover, the COVID-19 outbreak has led to an increase in social media usage worldwide, creating opportunities for the social commerce industry. As users have been spending more time on social media, they have discovered new social media platforms. For example, TikTok has witnessed an addition of over 12 million U.S.-based visitors in March 2020 alone, crossing the 2 billion mark in April.

The market is characterized by a high degree of competition due to the presence of numerous companies operating at a global level. Several social media companies have started offering a platform for retailers to buy or sell products. For instance, Facebook launched Marketplace in 2016 as a platform for people to do business in their local communities. People around the world can discover things they love on Facebook Marketplace and launch a business to earn a living.

Request a free sample copy or view report summary: Social Commerce Market Report

Social Commerce Market Report Highlights

  • The personal and beauty care segment is anticipated to register a CAGR exceeding 30% over the forecast period owing to the increasing demand in the Asia Pacific
  • The B2C segment held the largest market share of 49.53% in 2020, attributed to the increasing usage of social media platforms for buying and selling products
  • Asia Pacific captured a sizeable market share of 68.47% in 2020, due to the increasing number of social media users in countries such as India and China

Social Commerce Market Segmentation

Grand View Research has segmented the global social commerce market based on the business model, product type, and region:

Social Commerce Business Model Outlook (Revenue, USD Million, 2017 - 2028)

  • B2C
  • B2B
  • C2C

Social Commerce Product Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Personal & Beauty Care
  • Apparel
  • Accessories
  • Home Products
  • Health Supplements
  • Food & Beverage
  • Others

Social Commerce Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

List of Key Players of Social Commerce Market

  • Facebook
  • Pinterest
  • com (Alibaba)
  • Etsy, Inc.
  • Poshmark, Inc.
  • Twitter, Inc.
  • Paypal Payments Private Limited
  • Sina Corporation
  • Fab.
  • Reddit, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacovigilance Market Set to Record Exponential Growth by 2028

 

Pharmacovigilance Market Growth & Trends

The global pharmacovigilance market size is expected to reach USD 14.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. The increasing incidence of Adverse Drug Reactions (ADR) is the key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.

According to the World Health Organization's (WHO) report on pharmaceutical consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital setups. Hence, there has been a significant rise in the number of medicines made available to healthcare consumers. The rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV services to reduce costs and minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services. Companies are also adopting strategies including new product launches and mergers & acquisitions to gain a competitive advantage. Moreover, they are undertaking collaborations with the PV service providers to gain access to medical information and manage PV workflows. For instance, in September 2019, Accenture collaborated with Bayer to implement the company's INTIENT Clinical platform to simplify and speed up its drug development processes, thereby widening its business. The company collaborated with BioCelebrate in 2017 to develop a platform for aggregating and analyzing clinical information for improved drug development efficiency, thus enhancing its R&D capabilities. Such initiatives help companies maintain their market position.

Request a free sample copy or view report summary: Pharmacovigilance Market Report

Pharmacovigilance Market Report Highlights

  • By product life cycle, phase IV held a dominant share of 75.61% in 2020 owing to the extensive post-marketing surveillance of pharmaceuticals and an increasing number of ADR incidences in the market
  • In terms of service provider, contract outsourcing held a significant share of 59.24% as of 2020 owing to the shift in the focus of pharmaceutical companies to outsourcing services to reduce operational cost
  • Based on type, spontaneous reporting held the largest revenue share in 2020 due to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
  • On the basis of end-use, the biotechnology companies segment is anticipated to exhibit a lucrative CAGR of 12.6% over the forecast period owing to the increasing R&D for the development of novel biologics
  • Asia Pacific is anticipated to exhibit a lucrative CAGR of 13.2% in the forthcoming years. This is attributed to the availability of low-cost labor and the rising number of outsourcing companies in this region

Pharmacovigilance Market Segmentation

Grand View Research has segmented the global pharmacovigilance market on the basis of the service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2016 - 2028)

  • In-house
  • Contract Outsourcing

Pharmacovigilance Product Life Cycle Outlook (Revenue, USD Million, 2016 - 2028)

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Pharmacovigilance Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance Process Flow Outlook (Revenue, USD Million, 2016 - 2028)

  • Case Data Management
    • Case Logging
    • Case Data Analysis
    • Medical Reviewing & Reporting
  • Signal Detection
    • Adverse Event Logging
    • Adverse Event Analysis
    • Adverse Event Review & Reporting
  • Risk Management System
    • Risk Evaluation System
    • Risk Mitigation System

Pharmacovigilance Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others

Pharmacovigilance End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharmaceuticals
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Others

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Kingdom of Saudi Arabia

List of Key Players of Pharmacovigilance Market

  • Accenture
  • Linical Accelovance
  • IQVIA
  • Cognizant
  • Laboratory Corporation of America Holdings
  • IBM Corporation
  • ArisGlobal
  • ICON Plc.
  • Capgemini
  • ITClinical
  • TAKE Solutions
  • PAREXEL International Corporation
  • BioClinica, Inc.
  • Wipro Limited
  • UNITED BIOSOURCE CORPORATION
  • FMD K&L

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tuesday, 12 January 2021

India Online Grocery Market to Witness Tremendous Growth and Expansion by 2028

 India Online Grocery Market Growth & Trends

The India online grocery market size is projected to reach USD 38.9 billion by 2028, according to a study conducted by Grand View Research, Inc. It is expected to expand at a CAGR of 37.1% from 2021 to 2028. The online grocery market in India has been thriving with consumers favoring the convenience of online shopping over neighborhood grocery retailers. Amid the COVID-19 pandemic, people have been careful to step out from the safety of their homes.

A rising number of individuals are shifting toward online grocery shopping for meeting their needs during the time of social distancing. The online grocery market in India, while still in its nascent stage, witnessed remarkable growth during the pandemic period and is set to pick up significantly as social distancing becomes the new normal and as traditional grocery retailing loses appeal across hitherto experience. Additionally, growing smartphone usage, coupled with the proliferation of the internet, is a key factor expected to boost market growth over the forecast period.

Furthermore, a rise in investments of Venture Capital and Private Equity (PE) funds into India's consumer internet and online retail sectors are likely to support the growth of the market. Moreover, in the coming years, the industry is expected to be driven by consumers using local languages over English from Tier-I as well as Tier-II and III cities. Hence, key players in the market are looking forward to adapting their platforms to local languages and establish improved voice search features to build their potential consumer base. Other appealing offers like fast delivery or same-day delivery, low delivery charges, cashback offers, and flexible return policies by online grocery platforms are also expected to drive the market in the foreseeable future.

Online grocery shopping is seen to be highly convenient and user-friendly; however, it has its challenges. A personalized experience, lack of physical evidence, and checking the product for its freshness before the purchase is absent while shopping online. The growing awareness of fitness and well-being, eating fresh and healthy food raises concerns about buying groceries online. Moreover, frauds associated while making an online purchase and payments, delays in the delivery, and delivery of damaged or expired goods are some of the other factors that are likely to hinder the market growth. Nevertheless, the adoption of the Internet of Things (IoT) is projected to provide lucrative opportunities for the market over the forecast period. IoT aids e-commerce companies keep track of their inventory with the use of IoT enabled devices within the network. These IoT-enabled devices help retailers provide real-time data and analyze the demand for several products across different regions and cities.

Request a free sample copy or view report summary: India Online Grocery Market Report

India Online Grocery Market Report Highlights

  • Based on product type, the staples and cooking essentials segment dominated the market with a share of 33.9% in 2020 owing to the constant shopping of staples
  • The online payment method segment is expected to expand at the fastest CAGR over the forecast period. India’s online grocery market, traditionally dominated by cash, is evolving to meet the demands of its increasingly smartphone-led online shopping culture, with cards and digital wallets rising in prominence
  • By region, South India accounted for 34.6% share in 2020 and is expected to witness significant growth over the coming years. The West India region is anticipated to witness the second-highest growth over the forecast period

India Online Grocery Market Segmentation

Grand View Research has segmented the India online grocery market on the basis of product type, payment method, and region:

India Online Grocery Product Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Fresh Produce
  • Breakfast & Dairy
  • Snacks & Beverages
  • Meat & Seafood
  • Staples & Cooking Essentials
  • Others

India Online Grocery Payment Method Outlook (Revenue, USD Million, 2017 - 2028)

  • Online
  • Offline (Cash on Delivery)

India Online Grocery Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • South India
  • North India
  • West India
  • East India

List of Key players of India Online Grocery Market

  • Amazon India Pvt. Ltd.          
  • Godrej Nature's Basket Ltd.  
  • Grofers India Pvt. Ltd.
  • Paytm E-Commerce Pvt. Ltd. (Paytm Mall)  
  • Reliance Retail Ltd. (Reliance Fresh)
  • Spencer's Retail         
  • Supermarket Grocery Supplies Pvt. Ltd. (BigBasket)           
  • UrDoorstep eRetail Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-invasive Aesthetic Treatment Market Outlook & Future Forecast Report Till 2028

 Non-invasive Aesthetic Treatment Market Growth & Trends

The global non-invasive aesthetic treatment market size is expected to reach USD 18.5 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 13.9% over the forecast period. Non-invasive aesthetic treatment offer benefits, such as less pain, instant results, and low cost, over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging.

According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects for the market in the coming years. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.

Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the rapidly growing population in countries, such as India and China.

Request a free sample copy or view report summary: Non-invasive Aesthetic Treatment Market Report

Non-invasive Aesthetic Treatment Market Report Highlights

  • Injectable procedure is projected to be the leading procedure segment over the forecast period
  • Among various injectable procedures, botulinum toxin is one of the most widely used minimally invasive treatment
  • North America was the dominant regional market in 2020 accounting for a share of around 37% due to the availability and adoption of advanced treatment options in this region
  • Asia Pacific is projected to register the fastest CAGR over the forecast period on account of the rising target population in the region

Non-invasive Aesthetic Treatment Market Segmentation

Grand View Research has segmented the global non-invasive aesthetic treatment market on the basis of procedure and region:

Non-invasive Aesthetic Treatment Procedure Outlook (Revenue, USD Million, 2016 - 2028)

  • Injectables
    • Botulinum Toxin
    • Calcium Hydroxylapatite
    • Hyaluronic Acid
    • Polymer Filler
    • Collagen
  • Skin Rejuvenation
    • Chemical Peel
    • Laser Skin Resurfacing
    • Photorejuvenation
  • Others
    • Hair Removal
    • Nonsurgical Fat Reduction
    • Sclerotherapy
    • Cellulite Treatment

Non-invasive Aesthetic Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Non-invasive Aesthetic Treatment Market

  • Hologic, Inc.
  • Allergan, Inc.
  • Galderma S.A.
  • Alma Lasers
  • Syneron Candela
  • Johnson & Johnson
  • Merz Pharma
  • Lumenis
  • Solta Medical
  • Cutera, Inc.
  • Revance Therapeutics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Magnetic Resonance Imaging Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

 MRI Market Growth & Trends

The global magnetic resonance imaging market size is expected to reach USD 8.5 billion by 2028. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market. In addition, the growing adoption of less invasive procedures is also contributing to the growth of the market. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of magnetic resonance imaging (MRI) machines in various clinical applications is also expected to boost market growth.

End-users such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T. The growing number of research studies will help in unlocking the potential usage and advantages of high field MRI machines for various preclinical as well as clinical applications. Currently, 7T MRI machines are only effective in brain and knee imaging, largely due to the absence of advance coil required for these high field machines. Therefore, the development of advance coils to expand the application of 7T MRI machines is expected to propel market growth during the forecast period.

Key market players are adopting various strategies such as mergers and acquisitions, collaborations, and partnerships to be competitive in the market. Aurora Imaging Technology entered into a distribution agreement with Sumec Group Corporation. Under this distribution agreement, Sumec Corporation will distribute MRI portfolio ofAurora Imaging Technology in China. This, in turn, is helping both the companies in geographical expansion.

Request a free sample copy or view report summary: MRI Market Report

MRI Market Report Highlights

  • Adoption of advanced imaging technologies is augmenting the growth of the market
  • Open system is anticipated to be the fastest growing segment during the forecast period due to its efficiency to accommodate all size of patients without feeling claustrophobic
  • MRI for neurological and brain disorders dominated the market largely due to growing number of neurological conditions and increasing demand for less invasive diagnostic procedure
  • The high field segment is expected to experience fastest growth largely due to its efficiency to provide detailed images for diagnosis
  • Ambulatory surgical centers are expected to exhibit highest growth rate during the forecast period. Government initiatives to improve primary care is one of the major factor impacting the segment growth
  • In 2020, North America dominated the magnetic resonance imaging (MRI) market and accounted for the largest revenue share owing to continuous research and high adoption of advanced techniques in the region
  • Asia Pacific is anticipated to witness the fastest growth rate over the forecast period due to growing number of clinical studies in the region for high field MRI machines

MRI Market Segmentation

Grand View Research has segmented the global magnetic resonance imaging market based on architecture, field strength, application, end-use, and region:

MRI Architecture Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • Closed System
  • Open System

MRI Field Strength Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • Low Field Strength
  • Mid Field Strength
  • High Field Strength

MRI Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • Brain and neurological
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Spine and musculoskeletal
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Vascular
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Abdominal
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Cardiac
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Breast
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength
  • Other
    • Low Field Strength
    • Mid Field Strength
    • High Field Strength

MRI End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Imaging Centers
  • Ambulatory Surgical Centers
  • Others

MRI Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Italy
    • France
    • Spain
    • Sweden
    • Russia
    • The Netherlands
    • Austria
    • Belgium
    • Denmark
    • Norway
    • Portugal
    • Finland
  • Asia Pacific
    • India
    • China
    • Japan
    • Thailand
    • South Korea
    • Singapore
    • Malaysia
    • Philippines
    • Taiwan
    • Indonesia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar

List of Key Players of Magnetic Resonance Imaging Market

  • GE Healthcare
  • Hitachi Medical Systems America AG.
  • Siemens AG
  • Toshiba Corporation
  • Aurora Imaging Technologies, Inc.
  • Koninklijke Philips N.V.
  • Esaote SPA
  • Sanrad Medical Systems Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal Membrane Oxygenation Machine Market is Thriving USD 398.6 Million Revenue by 2028

 Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.

Request a free sample copy or view report summary: Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

  • North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
  • By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
  • In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
  • Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
  • On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period

Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the global extracorporeal membrane oxygenation machine market on the basis of component, modality, patient type, application, and region:

ECMO Machine Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

ECMO Machine Modality Outlook (Revenue, USD Million, 2016 - 2028)

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

ECMO Machine Patient Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Neonates
  • Pediatric
  • Adult

ECMO Machine Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Respiratory
    • Neonates
    • Pediatric
    • Adult
  • Cardiac
    • Neonates
    • Pediatric
    • Adult
  • ECPR
    • Neonates
    • Pediatric
    • Adult

ECMO Machine Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Czech Republic
    • Russia
    • Poland
    • Turkey
    • Switzerland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Vietnam
    • Philippines
    • Malaysia
    • Indonesia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Oman
    • Kuwait

List of Key Players of Extracorporeal Membrane Oxygenation Machine Market

  • Medtronic plc
  • Sorin Group
  • Terumo Cardiovascular Systems Corporation
  • MAQUET Holding B.V. & Co. KG
  • Medos Medizintechnik AG
  • Nipro Medical Corporation
  • Microport Scientific Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 11 January 2021

Medical Imaging Market Trends Regulations And Competitive Landscape Outlook to 2028

 Medical Imaging Market Growth & Trends

The global medical imaging market size is expected to reach USD 28.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. Increasing demand for advanced diagnostic systems in developing countries and growing trends of market player collaborations are some of the key factors driving the market.

Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players in the untapped market.

The integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the market at the global level.

The development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care.

Ongoing trials and studies to explore the potential of MRI technology for the early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.

Request a free sample copy or view report summary: Medical Imaging Market Report

Medical Imaging Market Report Highlights

  • By product, the ultrasound segment captured the largest share in 2020 and is expected to dominate throughout the forecast period. Computed tomography is expected to grow at the fastest rate during the forecast period due to rapid technological advancements, such as the development of hybrid imaging modalities and the integration of AI
  • Based on end use, the hospital's segment dominated the market in 2020 due to the blooming healthcare service industry in developing countries. The ambulatory imaging centers segment is anticipated to witness the fastest growth during the forecast period
  • North America captured the largest market share in 2020 due to the presence of a large number of industry players and the high frequency of new product launches

Medical Imaging Market Segmentation

Grand View Research has segmented the global diagnostic imaging market on the basis of product, end use, and region:

Medical Imaging Product Outlook (Revenue, USD Million, 2016 - 2028)

  • X-ray
    • By Modality
      • Radiography
      • Fluoroscopy
      • Computed Radiography
    • By Mobility
      • Stationary
      • Mobile
    • By Product
      • Digital
      • Analog
    • By Application
      • General radiology
      • Dental
      • Breasts
      • Cardiology
      • Others
    • Ultrasound
      • By Product
        • 2D
        • 3D/4D
        • Doppler Ultrasound Devices
      • By Portability
        • Handheld
        • Cart/Trolley Based
      • By Application
        • Ob/Gyn
        • Cardiovascular
        • Musculoskeletal
        • Others
      • Computed Tomography
        • By Technology
          • High-end slice
          • Mid-end slice
          • Low-end slice
          • Cone beam
        • By Application
          • Oncology
          • Neurology
          • Cardiology
          • Vascular
          • Musculoskeletal
          • Others
        • Magnetic Resonance Imaging
          • By Architecture
            • Closed System
            • Open System
          • By Field Strength
            • Low Field Strength
            • Mid Field Strength
            • High Field Strength
          • By Application
            • Brain and neurological
            • Spine and musculoskeletal
            • Vascular
            • Abdomen
            • Cardiac
            • Breast
            • Other
          • Nuclear Imaging
            • By Product
              • SPECT
                • Hybrid SPECT
                • Standalone SPECT
              • Hybrid PET
              • Planar Scintigraphy
            • By Application
              • Oncology
              • Cardiology
              • Neurology
              • General Imaging

Medical Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Imaging Centers
  • Others

Medical Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Switzerland
    • Turkey
    • Poland
  • Asia Pacific
    • China
    • Japan
    • India
    • Thailand
    • South Korea
    • Malaysia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Iran

List of Key Players of Medical Imaging Market

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • CANON MEDICAL SYSTEMS CORPORATION
  • Bruker
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions
  • TriFoil Imaging
  • PerkinElmer Inc.
  • FUJIFILM VisualSonics Inc.
  • Cubresa Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aesthetic Medicine Market Industry Size, Driving Demands, and Industry Share of Various Stakeholders

 Aesthetic Medicine Market Growth & Trends

The global aesthetic medicine market size is expected to reach USD 124.7 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.8% from 2021 to 2028. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is ‘a branch of medicine focused on satisfying the aesthetic desires and goals of patient. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Key drivers of the market include introduction of non-invasive medical devices for cosmetic procedures, growing focus on physical appearance, and rise in adoption among geriatric individuals.

Based on procedure type, the market is mainly divided into invasive and non-invasive procedures. Invasive procedures include breast augmentation, liposuction, and nose reshaping while non-invasive procedures include popular technology such as Botox injections, soft tissue fillers, and chemical peel. Rise in number of obesity cases in the U.S. has urged patients to opt for cosmetic treatments in the country.

In Asia Pacific, rise in income level of the adult population in countries such as China and India is expected to create lucrative opportunity for the market. The region is also backed by South Korea, which is the hub of cosmetic surgeries.

Request a free sample copy or view report summary: Aesthetic Medicine Market Report

Aesthetic Medicine Market Report Highlights

  • The non-invasive procedures segment is projected to dominate throughout the forecast period owing to its quicker and accurate results along with ease of usage compared to invasive procedures
  • Breast augmentation and liposuction are among the fastest growing under the invasive procedures segment in the forecast years
  • In Asia Pacific, the market is projected to witness a CAGR of 10.9% during the forecast period. Countries such as South Korea and India are expected to serve as key revenue pockets

Aesthetic Medicine Market Segmentation

Grand View Research has segmented the global aesthetic medicine market on the basis of procedure type and region:

Aesthetic Medicine Procedure Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Invasive Procedures
    • Breast augmentation
    • Liposuction
    • Nose reshaping
    • Eyelid Surgery
    • Tummy tuck
    • Others
  • Non-invasive Procedures
    • Botox injections
    • Soft tissue fillers
    • Chemical peel
    • Laser hair removal
    • Microdermabrasion
    • Others

Aesthetic Medicine Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Aesthetic Medicine Market

  • Allergan Inc.
  • Hologic (cynosure)
  • Johnson & Johnson
  • Galderma
  • Lumenis
  • Solta Medical
  • Syneron Candela
  • Alma Laser

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurothrombectomy Devices Market Expected to Deliver Dynamic Progression until By 2028

 Neurothrombectomy Devices Market Growth & Trends

The global neurothrombectomy devices market size is anticipated to reach USD 1.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. Increasing incidence of acute is chemic stroke, such as intracerebral and subarachnoid hemorrhagic stroke is anticipated to boost the market growth. For instance, according to the Stroke Alliance for Europe, the stroke incidence rate in Europe will increase by 34.0% from 2015 to 2035.

Furthermore, stroke remains the leading cause of death worldwide due to the adoption of a morbid lifestyle. For instance, in the U.S., around 70,000 stroke incidences are reported each year, out of which 23.0% are fatal or cause permanent disability. Moreover, smoking is another foremost risk factor responsible for ischemic or hemorrhagic stroke.

Technological advancements play a crucial role in driving the market. For instance, Medtronic’s Solitaire Platinum Revascularization neurothrombectomy device comprises of nitinol scaffolding design attached to a pushwire. This medical instrument is designed to reduce around 70.0% of stroke-related disability and to improve the functional outcome at 90 days in patients suffering a large vessel occlusion.

Request a free sample copy or view report summary: Neurothrombectomy Devices Market Report

Neurothrombectomy Devices Market Report Highlights

  • On the basis of product, the clot retrievers segment dominated the market in 2020 and accounted for a revenue share of 58.3% owing to an increasing number of patients suffering from acute ischemic stroke due to large vessel occlusion
  • Based on end use, the hospital segment dominated the market in 2020 and accounted for the largest revenue share of 70.9% owing to the rising incidence of strokes and growing awareness regarding neurothrombectomy procedures
  • However, ambulatory surgical centers is anticipated to be the fastest-growing segment over the forecast period. This is attributed to a shorter waiting time that ASCs provide to the patients and an increasing number of ASC facilities
  • Europe dominated the market with the highest revenue share of 32.2% in 2020 and is expected to witness the highest CAGR owing to the presence of well-developed healthcare facilities and favorable reimbursement policies

Neurothrombectomy Devices Market Segmentation

Grand View Research has segmented the global neurothrombectomy devices market on the basis of product, end use, and region:

Neurothrombectomy Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Clot Retrievers
  • Aspiration/Suction Devices
  • Vascular snares

Neurothrombectomy Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Emergency Clinics
  • Ambulatory Surgical Centers

Neurothrombectomy Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Neurothrombectomy Devices Market

  • Medtronic
  • Stryker Corporation
  • Acandis GmbH
  • Stryker
  • Phenox GmbH
  • Penumbra Inc.
  • Vesalio

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Clinical Trials Market Poised to Expand at a Robust Pace of USD 9.9 Billion Over 2027: Grand View Research Inc.

 COVID-19 Clinical Trials Market Growth & Trends

The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth. Also, the underlying economic profits for first movers are encouraging pharmaceutical players to invest in clinical trial studies for COVID-19.

The current pandemic poses an acute health risk to the entire population. A key to successfully fighting COVID-19 lies in clinical research. At present, almost all the major research-based pharmaceutical companies, many other biotechnology and pharmaceutical companies, as well as research institutes are engaged in a race to develop an effective treatment against coronavirus. There are currently 661 unique compounds in development against COVID-19, of which 292 are drugs, 173 are vaccines and 196 are antivirals.

The regulators in the U.S. and Europe also offer various options for action and procedural facilitation to enable faster access to effective vaccines and drugs to combat the pandemic. In March 2020, the Solidarity Trial-an international clinical trial by the World Health Organization (WHO)-was launched to find effective treatment against COVID-19. In May 2020, WHO also announced an international alliance for developing various candidate vaccines to stop the spread of coronavirus disease, calling this effort the Solidarity trial for vaccines.

The current scenario across the globe and the need to come up with treatment options has also led to the fast-track of clinical trials. Hence, in March 2020, the Food and Drug Administration (FDA) launched a Coronavirus Treatment Acceleration Program (CTAP) for the likely therapies to accelerate the development of the treatment for the pandemic caused by a coronavirus. Recently in May 2020, the U.S. FDA granted fast track title to Moderna’s mRNA vaccine candidate, mRNA-1273, to protect against COVID-19.

Request a free sample copy or view report summary: COVID-19 Clinical Trials Market Report

COVID-19 Clinical Trials Market Report Highlights

  • Phase II COVID-19 clinical trials dominated the market with a share of 35.0% in 2020. This is attributed to the maximum number of products currently in development.
  • The vaccines segment accounted for the largest share of 77.1% in 2020 owing to the increasing investments towards it.
  • Europe held 46.8% of the market share in 2020. Favorable government initiatives such as the UK’s “ACCORD” clinical trial program are contributing to market growth.
  • The Asia Pacific region is projected to witness the fastest CAGR of 11.8% during the forecast period as the increasing number of biotechnology firms are looking at the region for their COVID-19 trials to take advantage of the large patient pool and fast-track procedures.

COVID-19 Clinical Trials Market Segmentation

Grand View Research has segmented the global COVID-19 clinical trials market based on phase, product, and region:

COVID-19 Clinical Trials Market Phase Outlook (Revenue, USD Million, 2016 - 2027)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Others

COVID-19 Clinical Trials Market Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Therapeutics
  • Vaccines

COVID-19 Clinical Trials Market Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • The Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of COVID-19 Clinical Trials Market

  • Moderna, Inc.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Johnson & Johnson
  • Gilead Sciences Inc.
  • INOVIO Pharmaceuticals
  • AbbVie Inc.
  • BioNTech SE
  • Novavax
  • Takeda

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ecotoxicological Studies Market to Reach Around USD 1.3 Billion by 2027: Grand View Research Inc.

 Ecotoxicological Studies Market Growth & Trends

The global ecotoxicological studies market size is expected to reach USD 1.3 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.6% from 2021 to 2027. Ecotoxicological studies are conducted to estimate the effects of toxic substances on an ecosystem and are based on scientific research by both laboratory and field methods. The growth of the pharmaceutical and biopharmaceutical industries is likely to drive the market. Stringent regulatory requirements and favorable government support are further contributing to market growth. Most regulatory authorities require ecotoxicity testing using various organisms. The U.S. Environmental Protection Agency (EPA) recommends specific tests, organisms, and toxicity endpoints to calculate the risk from Plant Protection Products (PPPs), such as pesticides, and has developed guidelines for ecological risk assessments to assess the likelihood of plant and wildlife toxicity as well as environmental fate.

The increasing number of chemicals such as synthetic hormones and pharmaceuticals are used on a daily basis all over the world. In Europe, approximately 100,000 chemicals are currently used during the manufacturing of drugs. With the exception of pesticides that are released into the environment purposely, many chemicals enter the environment due to their use through different paths. Hence, to assess risks from chemicals to the ecosystem, toxicity data on chemicals is required.

Ecotoxicological studies are conducted and reported as per the globally validated standard test guiding principles and Good Laboratory Practices (GLPs). For instance, GPLs provided by the U.S. Environmental Protection Agency (EPA) and Organization for Economic Co-operation and Development (OECD) are required by many regulatory frameworks for environmental or ecological hazard and risk assessment of chemicals. There are various documents that include requirements of environmental safety, such as the Biocidal Product Directive (BPR), OSPAR, and European REACH regulation.

Request a free sample copy or view report summary: Ecotoxicological Studies Market Report

Ecotoxicological Studies Market Report Highlights

  • Based on service, the aquatic ecotoxicology segment dominated the market with a share of 43.6% in 2020 as major regulatory bodies across the globe mandate evidence of the potential hazard of drugs to aquatic organisms and ecosystems
  • The sediment ecotoxicology service segment is expected to expand at the highest CAGR of 3.9% over the forecast period as sediment ecotoxicology studies are conducted on a large scale by pharmaceutical companies. Sediments can adsorb persistent pollutants and thereby act as a long-term source of pollution for surface water
  • Europe dominated the market in 2020 with a share of 34.0% due to the favorable government support and the presence of various regulatory bodies, such as the European Chemical Agency (ECHA); Registration, Evaluation, Authorization and Restriction of Chemicals (REACH); and the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Polymers Task Force
  • Asia Pacific is anticipated to register the highest CAGR over the forecast period owing to the improved regulatory frameworks, the high scope for cost savings, and growing industrialization leading to the establishment of pharmaceutical companies in the region

Ecotoxicological Studies Market Segmentation

Grand View Research has segmented the global ecotoxicological studies market based on service and region:

Ecotoxicological Studies Service Outlook (Revenue, USD Million, 2016 - 2027)

  • Aquatic Ecotoxicology
  • Sediment Ecotoxicology
  • Terrestrial Ecotoxicology
  • Avian Ecotoxicology
  • Pollinator Testing

Ecotoxicological Studies Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Ecotoxicological Studies Market

  • Smithers
  • SGS SA
  • Covance, Inc.
  • INTOX Pvt. Ltd.
  • Fera Science Limited
  • Charles River Laboratories
  • Noack Laboratorien GmbH
  • Eurofins Agroscience Services Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Electric Bed Market is Anticipated To Generate Significant Revenues by 2027: Grand View Research Inc.

 Electric Bed Market Growth & Trends

The global electric bed market size is expected to reach USD 3.80 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2021 to 2027. The increasing number of accident cases across the globe, the growing geriatric population, the rising number of surgical procedures globally, and the recent outbreak of COVID-19 are the key factors driving the market.

The number of road accidents is rapidly increasing, leading to a rise in the need for electric beds in hospitals and clinics. For instance, according to the Association for Safe International Road Travel (ASIRT), around 20.00 to 50.00 million people are injured or disabled every year. Road traffic accidents are the 9th leading cause of death worldwide. ASIRT also reported that in the U.S., more than 37,000 people die in road accidents per year and around 2.35 million are injured or disabled. In some cases, road accidents require immediate surgery and care, and thus in such cases, an electric bed is one of the essential requirements.

As per the Ministry of Road Transport and Highways, Government of India, in 2016, around 494,624 people were injured in road accidents. This number has increased by 25.6% from 2007 to 2017. In 2016, the states that recorded the highest number of road accidents were Uttar Pradesh (25,096), Tamil Nadu (82,163), Maharashtra (35,884), and Karnataka (54,556). Therefore, such instances indicate considerable growth of the market over the forecast period. In addition, the growing geriatric population, which is more susceptible to various diseases, and increasing hospital admissions are anticipated to propel the market growth. For instance, as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2015 to 2016. Hence, the increasing geriatric population is also expected to propel the market growth over the forecast period.

Request a free sample copy or view report summary: Electric Bed Market Report

Electric Bed Market Report Highlights

  • In terms of product, the semi-automatic electric bed segment held the largest share in 2020. The increasing number of hospital admissions across the globe is expected to fuel the segment growth over the forecast period
  • Based on application, the general bed segment held the largest market share in 2020 owing to the rising number of accident cases across the globe
  • By end use, the hospitals and clinics segment is anticipated to witness the fastest growth over the forecast period owing to the increasing number of hospital admissions due to the recent outbreak of COVID-19
  • Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local key players

Electric Bed Market Segmentation

Grand View Research has segmented the global electric bed market on the basis of product, application, end use, and region:

Electric Bed Product Outlook (Revenue, USD Million, 2015 - 2027)

  • Semi-automatic Electric Bed
  • Fully Automatic Electric Bed

Electric Bed Application Outlook (Revenue, USD Million, 2015 - 2027)

  • General Bed
  • Intensive Care Bed
  • Bariatric Bed
  • Birthing Bed
  • Others

Electric Bed End-use Outlook (Revenue, USD Million, 2015 - 2027)

  • Hospitals & Clinics
  • Reproductive Care Centers
  • Dentistry
  • Others

Electric Bed Regional Outlook (Revenue, USD Million, 2015 - 2027)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

List of Key Players of Electric Bed Market

  • Arjo
  • Hill-Rom Services Inc.
  • Medline Industries, Inc.
  • Paramount Bed Co., LTD.
  • Invacare Corporation
  • Stryker
  • Malvestio Spa
  • LINET
  • Gendron Inc.
  • Midmark India Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...